NASDAQ: KURA       Kura Oncology
Last Price Today's Change   Day's Range   Trading Volume
34.75   -0.31 (0.88%)  34.75 - 35.30  12,968


Avg Volume (4 weeks):641,323
4 Weeks Range:32.17 - 40.01
4 Weeks Price Volatility (%):
52 Weeks Range:6.35 - 43.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2929  3245  432  3293 

Top 10 Active Counters
 LK 1.38+1.38 
 WPX 9.43+0.48 
 NAKD 0.515+0.079 
 CLSN 2.38+1.105 
 HTZ 0.00-1.75 
 GPOR 0.1380.00 
 CTRM 0.338+0.013 
 ACST 0.922+0.165 
 AMTD 39.97-0.85 
 PE 16.93+0.52